SWISS INNOVATION
PATHELEN® HYBRID
A new and innovative wound treatment!
PATHELEN® Hybrid is a combination of active ingredients of hydrophilic and hydrophobic fumed silica, which physically adsorb wound exudate, promoting an optimal environment for wound healing.
CASE STUDIES
In recent years, the PATHELEN® HYBRID therapy has been tested on patients in various hospitals and has been continuously developed. A wide variety of wound infections were successfully treated until the patient had completely healed and recovered.
Case studies of successful treatments for MRSA infected wounds
COMPANY
Find out more about us
Pathelen Health Care AG is a Swiss biotech company that, in more than 7 years of research and development, has developed innovative forms of therapy for the treatment and healing of various diseases.
Pathelen Health Care AG has specialized in the therapeutic area of biofilm and pathogenic germs, in particular multi-resistant germs (such as MRSA or A. Baumannii).
We are cooperation partners of the Pathelen Medical Institute, the premium health institute in the heart of Estepona, in southern Spain.
